Antiviral agents for COVID-19.
Chinese Journal of Clinical Infectious Diseases
; 13(2):92-101, 2020.
Artículo
en Chino
| EMBASE | ID: covidwho-2305899
ABSTRACT
In December 2019, the endemic of COVID-19 broke out in Wuhan, China. The disease is highly contagious and quickly spreads at home and abroad, causing great concern. However, there are no definite effective antiviral drugs in clinical use. Given the urgency of the COVID-19 outbreak, based on the diagnosis and treatment recommendation and relavant researches, this article describes the optional antiviral drugs such as remdesivir, oseltamivir, arbidol, lopinavir/ritonavir, ribavirin, and interferon-alpha to provide a reference for treatment of COVID-19.Copyright © 2020 by the Chinese Medical Association.
2019-nCoV; Antiviral therapy; covid-19; Drugs; article; coronavirus disease 2019/dt [Drug Therapy]; priority journal; alpha interferon/dt [Drug Therapy]; lopinavir plus ritonavir/dt [Drug Therapy]; oseltamivir/dt [Drug Therapy]; remdesivir/dt [Drug Therapy]; ribavirin/dt [Drug Therapy]; umifenovir/dt [Drug Therapy]
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
EMBASE
Idioma:
Chino
Revista:
Chinese Journal of Clinical Infectious Diseases
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS